Premature Infant Clinical Trials

Find Premature Infant Clinical Trials Near You

Randomized Controlled Trial of Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants: Enhancing Stress Regulation, Neurodevelopment, and Oral Feeding Skills

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if the multisensory early oral administration of human milk (M-MILK) intervention helps infants who are born younger than 32 weeks gestational age (very preterm infants). The main question that this clinical trial aims to answer is: Does M-MILK improve stress regulation, support optimal neurodevelopment, and promote competent oral feeding skills in very preterm infants? Researchers will compare M-MILK to the standard of care to see if M-MILK helps very preterm infants. Specifically, researchers will compare the differences in: * Cortisol levels * DNA methylation of the two stress related genes (NR3C1 and HSD11B2) * Neurodevelopment * Oral feeding skills Participants in the M-MILK group will receive standard of care plus M-MILK intervention, which starts on day 3 of life and continues until they begin their oral feeding. M-MILK will be provided by clinical research nurses, during the day shift, up to 4 times a day. Participants in the standard of care group will continue to receive their usual care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5 months
Maximum Age: 7 months
Healthy Volunteers: f
View:

• Born at ≤ 32 weeks gestational age.

• Receiving mother's own milk and/or donor human milk at the time of screening.

Locations
United States
Illinois
Loyola University Chicago
RECRUITING
Maywood
Loyola University Medical Center
RECRUITING
Maywood
Contact Information
Primary
Thao Griffith, PhD
tgriffith1@luc.edu
464-220-9825
Backup
Cara Joyce, PhD
cjoyce6@luc.edu
464-220-9521
Time Frame
Start Date: 2025-11-03
Estimated Completion Date: 2031-05-31
Participants
Target number of participants: 125
Treatments
Experimental: M-MILK Group
Infants in the M-MILK group will receive M-MILK intervention and standard of care. M-MILK is implemented starting on day 3 of life, during the day shift, after every hands-on care, during the beginning of a full gavage feeding, and up to 4 times a day. Infants receive M-MILK in small droplets via a 1-ml syringe. M-MILK will cease upon oral feeding initiation. Infants will receive either mother's own milk or donor's milk based on availability. Infants may receive up to 1 mL of milk each time based on their cues and responses. The 1 mL volume intake is included as part of their oral caloric intake. M-MILK is provided by research nurses or parents.
No_intervention: Control Group
Infants in the Control group will receive standard of care.
Related Therapeutic Areas
Sponsors
Leads: Loyola University
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Rush University Medical Center

This content was sourced from clinicaltrials.gov